stipetherapeutics.com

Stipe Therapeutics


STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regulator of tumorigenesis and autoimmune disorders. The company has identified and validated compounds that sensitizes the STING pathway and by this modulates the tumor microenvironment to support a potent anti-tumoral response.
View Top Employees for Stipe Therapeutics
img Website stipetherapeutics.com
img Industry Biotechnology
img Employees 18
img Founded 2018
img Website stipetherapeutics.com
img Industry Biotechnology
img Employees 18
img Founded 2018
img LinkedIn linkedin.com/company/stipe-therapeutics
img Funding 20,000,000 EUR

Top Stipe Therapeutics Employees